The DOI matches its Crossref record; 112 of the 114 references it cites were found in a registry or an index.
Spinal muscular atrophy—recent therapeutic advances for an old challenge
Abstract
In the past decade, improved understanding of spinal muscular atrophy (SMA) aetiopathogenesis has brought us to a historical turning point: we are at the verge of development of disease-modifying treatments for this hitherto incurable disease. The increasingly precise delineation of molecular targets within the survival of motor neuron (SMN) gene locus has led to the development of promising therapeutic strategies. These novel avenues in treatment for SMA include gene therapy, molecular therapy with antisense oligonucleotides, and small molecules that aim to increase expression of SMN protein. Stem cell studies of SMA have provided an in vitro model for SMA, and stem cell transplantation could be used as a complementary strategy with a potential to treat the symptomatic phases of the disease. Here, we provide an overview of established data and novel insights into SMA pathogenesis, including discussion of the crucial function of the SMN protein. Preclinical evidence and recent advances from ongoing clinical trials are thoroughly reviewed. The final remarks are dedicated to future clinical perspectives in this rapidly evolving field, with a broad discussion on the comparison between the outlined therapeutic approaches and the remaining open questions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, intrathecal ASO injection to human was successfully completed in the Phase I and II clinical trials (Faravelli et al., 2015).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Faravelli et al., 2015
In the citing paper
“Both trials demonstrated that intrathecal ASO injection is safe and effective.”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Faravelli et al., 2015
In the citing paper
“In addition, intrathecal ASO injection to human was successfully carried out in the phase I and II clinical trials [143].”
From MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease (2016) · cites this paper as [143]
In the citing paper
“In both clinical trials, the intrathecal ASO injection was safe and effective.”
From MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease (2016) · cites this paper as [143]
In the citing paper
“In both clinical trials, the intrathecal ASO injection was safe and effective.”
From MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease (2016) · cites this paper as [143]
Citations
Cites
1 retracted
Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H. M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1610 · Cited by 688
RetractedIdentification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,536
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,005
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E., Schroth, M. K., Simonds, A. K., Wong, B. L. Y., Aloysius, A., Morrison, L. A., Main, M. L., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 964
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 951
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 745
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 744
Research works printed but not linked: 2
- Mitrpant, C. et al. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS ONE 8, e62114 (2013). · DOI
- Titus, S. et al. High throughput screening for SMA. Probe Reports from the NIH Molecular Libraries Program [online] , (2010).
Cited by
Sorted by citations
Items 101–140 of 140
Neuromuscular diseases: Recent advances in antisense oligonucleotide therapy
Verma, A. K. (2018) · Astrocyte · doi:10.4103/astrocyte.astrocyte_55_18 · Cited by 2
Zhang, Y.-H., Zhang, Y., Zhu, B., He, J., Wang, L., Tang, X., Guo, J., Jin, C.-C., Chen, H., Zhang, J., et al. (2019) · PubMed Central · doi:10.7499/j.issn.1008-8830.2019.03.010 · Cited by 2
Novikova, E. S. (2023) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2023.3.11 · Cited by 2
Posibilidades de tratamiento en la atrofia espinal infantil
Pascual, S. I. P., & Romero, M. D. M. G. (2017) · Revista de Neurología · doi:10.33588/rn.64s03.2017173 · Cited by 2
Cook, S. L., Mensa, T., Noma, H., Jahnke, M., Vidal‐Folch, N., Stout, C., Hrstka, R. F., Hrstka, S., Kirkeby, L. A., Oglesbee, D., et al. (2025) · Neuromuscular Disorders · doi:10.1016/j.nmd.2025.106310 · Cited by 1
Abati, E., Saccomanno, D., Alberti, C., Anastasia, A., Gagliardi, D., Ferri, E., Arosio, B., Angelo, G. D., Cima, R., Bassi, M. T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-49537-5 · Cited by 1
Self-citationMiranda, H. C., & Spada, A. R. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-30582-0_11 · Cited by 1
Ryznychuk, М. О., Kryvchanska, M. I., Lastivka, I. V., Хмара, Т. В., & GONCHARENKO, V. A. (2018) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2018.53.2.12 · Cited by 1
Геннадьевич, М. В., Ponomareva, N. Y., Макарова, В., Милагина, В. С., Ямпольская, Е. Н., & Kochetkov, A. V. (2019) · Journal of clinical practice · doi:10.17816/clinpract10194-100 · Cited by 1
Induced pluripotent stem cells for modeling of X-linked dystonia-parkinsonism
Raković, A., Weißbach, A., Seibler, P., & Klein, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00008-9 · Cited by 1
Spinal Müsküler Atrofisi Olan Çocuk ve Ailesinin Hemşirelik Bakımı
Kostak, M. A., & Çetintaş, İ. (2022) · Etkili Hemşirelik Dergisi · doi:10.46483/deuhfed.982436 · Cited by 1
Spinal Muskuler Atrofisi Olan Çocuğun Hemşirelik Bakımı
Korkmaz, N., Şahin, K., & Balcı, S. (2023) · Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi · doi:10.51261/yiu.2023.1271182 · Cited by 1
Addressing Cell Therapy for Spinal Muscular Atrophy
Faravelli, I., & Corti, S. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00022-7 · Cited by 1
Self-citationA preimplantation genetic testing of monogenic diseases. Description of clinical case
Kogan, I. Y., Yakovlev, P., Gzgzyan, A. M., Дмитриевна, М. И., Maretina, M. A., Ivaschenko, T. E., Владимировна, М. Е., & Krikheli, I. O. (2018) · Journal of obstetrics and women s diseases · doi:10.17816/jowd67192-95 · Cited by 1
Hypotonia and Failure to Thrive in a 6-week-old Infant
Carter, E., Malchodi, L., & Marchegiani, S. (2019) · Pediatrics in Review · doi:10.1542/pir.2016-0081 · Cited by 1
Simon, V. A. (2016) · doi:10.11606/t.5.2016.tde-06092016-160616
Development and Translation of Therapies for Spinal Muscular Atrophy
Shorrock, H. K., & Gillingwater, T. H. (2016) · EMJ Neurology · doi:10.33590/emjneurol/10312757
HAVING A GO AT SPINAL MUSCULAR ATROPHY WITH SPINRAZA
Ommurugan, B., Amita, D., Rt, S., & Ap, N. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i6.17502
Feasibility of combined treatment for type III spinal muscular atrophy: a pilot study
Sych, N., Klunnyk, M. O., Matiyashchuk, I. G., Demchuk, M., Ivankova, O. V., Sinelnyk, A., Sorochynska, K., & Skalozub, M. (2017) · Journal of Neurorestoratology · doi:10.2147/jn.s138227
Cellular Therapy for Spinal Muscular Atrophy
Faravelli, I., & Corti, S. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00011-0
Self-citationNagimtayeva, A. A., Zhanataeva, D., Kamalieva, B., & Abildinova, G. Z. (2017) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/1812-2892-jcmk-00484
Single-Cell Transcriptomics and Proteomics of Skeletal Muscle: Technology and Applications
Cagnin, S., Chemello, F., Alessio, E., & Lanfranchi, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814919-5.00013-0
Diagnostic criteria for spinal muscular atrophy 5q
Валентиновна, Ш. И., Леонидовна, Д. Е., & Nikitin, S. S. (2021) · Neuromuscular Diseases · doi:10.17650/2222-8721-2021-11-3-37-44
Gaspar, B. L., Vasishta, R. K., & Radotra, B. D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1462-9_15
Modern View of SMA: Present and Future (Literature Review)
Рушкевич, Ю. Н., Мальгина, Е. В., Куликова, С. Л., Мирзоян, А. Р., & Лихачев, С. А. (2021) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2020.10.4.040
Fletcher, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732298839.793560194
MicroRNAs in neurological diseases
Tsujimura, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00002-9
Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
Пантелеева, М. В. (2022) · Russian Journal of Child Neurology · doi:10.17650/2073-8803-2022-17-3-37-42
Prevalence of OCD among Academics in a Public University: A Moderating Role of Power of Influence
Abdullah, M. Z., Othman, A. K., Rashid, M. A. A., Saidon, J., Aluwi, A. H., Haidir, N., & Suryanto, T. (2023) · Advances in Social Sciences Research Journal · doi:10.14738/assrj.106.2.15013
Reddy, P. J., Rao, K. V. P., & Reddy, P. A. (2025) · International Journal of Information Technology · doi:10.1007/s41870-025-02727-2
Yao, M., Jiang, L., Yu, Y., Cui, Y., Chen, Y., Zhou, D., Gao, F., & Shanshan, M. A. O. (2024) · Figshare · doi:10.6084/m9.figshare.26691580
Yao, M., Jiang, L., Yu, Y., Cui, Y., Chen, Y., Zhou, D., Gao, F., & Shanshan, M. A. O. (2024) · Figshare · doi:10.6084/m9.figshare.26691583
Yao, M., Ma, Y., Qian, R., Xia, Y., Yuan, C., Bai, G., & Shanshan, M. A. O. (2021) · Figshare · doi:10.6084/m9.figshare.13535494
Corti, S. P., Gadaleta, G., Bitetti, I., Crescimanno, G., D’Amico, A., Dosi, C., Masson, R., Patanella, A. K., Pera, M. C., Rao, F., et al. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125835
Self-citationMécanismes moléculaires à l'origine de la dysautonomie familiale
Hervé, M. (2016) · theses.fr (ABES) · doi:10.70675/6564ee49z2810z4387zb80azee2206033835
Unravelling the tangle of motor neuron diseases : insights from neuroimaging and neurophysiology
Querin, G. (2019) · theses.fr (ABES) · doi:10.70675/30ad3e2az5051z4364z9ec1z4b8d1f952b7b
Batista, E. C., Zanoteli, E., Fonseca, H. A. R., Polido, G. J., Saute, J. A. M., Ortega, A., França, M. C., Oliveira, A. S. B., de Souza, P. V. S., Gurgel‐Giannetti, J., et al. (2026) · Clinical Genetics · doi:10.1111/cge.70176
Vidal‐Folch, N., Stout, C., Winters, J., Oglesbee, D., Hasadsri, L., & Cook, S. L. (2026) · BMC Medical Genomics · doi:10.1186/s12920-026-02406-6
BindingDB Entry 50001709: Discovery of
BindingDB (2020) · UC San Diego · doi:10.7270/q2wh2sj9
BindingDB (2024) · UC San Diego · doi:10.7270/q20v8j1b
Metadata
- Authors
- Faravelli, I., Nizzardo, M., Comi, G. P., & Corti, S.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Corti, Stefania
- Venue
- Nature Reviews Neurology
- Published
- 2015-05-19
- Volume
- 11
- Issue
- 6
- Pages
- 351-359
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W1518213415
- Cited by
- 138
- References
- 114
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 15 · 2020: 8 · 2019: 15 · 2018: 19 · 2017: 20 · 2016: 25 · 2015: 6
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- spinal muscular atrophy, SMN protein, disease-modifying therapy, gene therapy, antisense oligonucleotides, small molecules, stem cell transplantation, clinical trials
- MeSH terms
- Animals, Clinical Trials as Topic, Diagnosis, Differential, Humans, Motor Neurons, Muscular Atrophy, Spinal, Oligonucleotides, Antisense, SMN Complex Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
